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Background: Conjugated and drug loaded silver nanoparticles are getting an increased attention for various
biomedical applications. Nanoconjugates showed significant enhancement in biological activity in comparison to
free drug molecules. In this perspective, we report the synthesis of bioactive silver capped with 5-Amino-β-resorcylic
acid hydrochloride dihydrate (AR). The in vitro antimicrobial (antibacterial, antifungal), enzyme inhibition (xanthine
oxidase, urease, carbonic anhydrase, α-chymotrypsin, cholinesterase) and antioxidant activities of the developed
nanostructures was investigated before and after conjugation to silver metal.
Results: The conjugation of AR to silver was confirmed through FTIR, UV–vis and TEM techniques. The amount of
AR conjugated with silver was characterized through UV–vis spectroscopy and found to be 9% by weight. The
stability of synthesized nanoconjugates against temperature, high salt concentration and pH was found to be good.
Nanoconjugates, showed significant synergic enzyme inhibition effect against xanthine and urease enzymes in
comparison to standard drugs, pure ligand and silver.
Conclusions: Our synthesized nanoconjugate was found be to efficient selective xanthine and urease inhibitors in
comparison to Ag and AR. On a per weight basis, our nanoconjugates required less amount of AR (about 11 times)
for inhibition of these enzymes.
Keywords: 5-Amino-β-resorcylic acid hydrochloride dihydrate, Silver nanoparticles, Urease, Xanthine oxidaseBackground
In the new research areas of science, the research field
of metal nanoparticles is an extensive and the most
emerging field. The huge surface area of the metal nano-
particles is responsible for their diverse optical, chemical,
magnetic, mechanical, and catalytic properties as com-
pared to large bulk materials [1,2]. Different methods
like the chemical, physical, and biological methods are
reported for the metal nanoparticles synthesis [3-8].
Silver nanoparticles (AgNPs) have been synthesized
using various methods, i.e. polysaccharide method, tollens
method, irradiation method, biological, polyoxometalates.
Silver is well-known for its antimicrobial activities and* Correspondence: syedasohailanaz@yahoo.com
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unless otherwise stated.has been utilized for years towards biomedical appli-
cations [9].
Current research showed that conjugation of Ag to
plant extracts boosted the enzyme inhibition and anti-
microbial activities but these reports are not very sys-
tematic [10,11]. In this context the aim of our present
work is to synthesize AgNPs from a synthetic biocide 5-
Amino-β-resorcylic acid hydrochloride dihydrate (AR).
The choice of AR towards facile synthesis of AgNPs
seems to be original one and may present several advan-
tages in terms of water solubility, possibility to conjuga-
tion to Ag metal due to the presence of carboxylic, amino
and phenolic hydroxyl groups. To ascertain the potential
of the synthesized nanoconjugates for in vivo applications,
the stability of the suspensions was investigated against
several parameters such as pH, temperature and salt con-
centration. Barron AgNPs (Ag) was prepared by reduction. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Comparative UV–vis spectra of AR and AgAR.
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fungal, enzyme inhibition (xanthine oxidase, urease, car-
bonic anhydrase, α-chymotrypsin, cholinesterase) and
antioxidant activities of AgAR nanoconjugates were
compared with pure AR, Ag and the commercially avail-
able antibiotics, enzyme inhibitors and antioxidants.
Results and discussion
The synthesis of AR (Figure 1) was carried out according
to our previously published procedure [12]. When the
synthesized AR was added to the aqueous solution
AgNO3, we observed a change in color from light brown
to dark brown upon slow addition of NaBH4 (Additional
file 1: Figure S1). Characterization of AgNPs with UV–
vis spectroscopy showed surface plasmon resonance
peak at 390 nm and the amount of AR conjugated with
the surface of silver was found to be 9% by weight
(Figure 2).
FTIR spectra of AR was recorded before and after
formation of nanoparticles and reported in Figure 3. The
disappearance of the peak at carbonyl region (1639 cm−1)
in the spectrum of AR indicated the chelation of car-
boxylic group with silver. From FTIR characterization, a
mechanism has been proposed for the synthesis of AgAR
nanoconjugates and reported in Figure 4. This figure
showed that NaBH4 has been involved in reduction of
AgNO3 while carboxylic group of AR provide stability to
AgNPs via electrostatic interactions [13]. The formation
of silver nanoparticles was finally confirmed from trans-
mission electron micrograph and the mean size of the
nanoparticles was found to be 8 nm (Figure 5).
In order to determine the potential of synthesized
nanoparticles for in vivo applications, it was desired to
check its stability against high concentration of NaCl,
heat and pH. The synthesized nanoconjugates was found
to be basic in nature as its pH was found to be 8.49. The
stability of nanoparticles was checked at all pH values
ranging from 2–13 (Figure 6) and indicated by observing
a change in λmax. In comparison to other pH values, as
the absorbance of nanoparticles was highest at pH 8–9
therefore, it was established that the stability of the
nanoconjugates was good at this pH.
When NaCl was added to the nanoparticles solution, a
gradual change in the peak shape is observed; an initialFigure 1 Synthesis of 5-Amino-β-resorcylic acid hydrochloride dihydrhalide surface layer of unknown structure may form very
rapidly (Figure 7). The successive changes in the UV-
visible spectra proposed that this layer may have deve-
loped into a silver halide layer. For NaCl, the onset
concentration for aggregation is considerably lower. This
has been discussed in terms of a distinct effect on the
nanoparticles surface, in which the surface charge is
dropped by nearly a factor of 2. It is not clear that how
this is accomplished. One probability is that a chloride
layer decreased the number of adsorption sites for the
highly charged AR. Instead, the chloride ion may substi-
tute AR entirely but then form AgCl2 rather than AgCl,
thereby retaining a negatively charged surface but with a
lesser value [14].
Figure 8 showed the absorption spectra of 8 nm AgNPs
at 100°C. The result indicated that the temperature effect
is negligible, resulting in a very minute reduction in
absorbance while a broadening of the plasmon band was
not observed.
In the present study, a systematic comparative bio-
activity evaluation of synthesized AR, Ag, AgAR and
standard drugs was carried out. AgAR nanoconjugates
contain 9% of AR as determine from UV–vis study. The
purpose of the conjugation of AR to the surface of AgNPs
is to determine the change in the activity of AR after
attachment to the surface of metal. Selected bioassaysate (AR).
Figure 3 Comparative FTIR spectra of AR and AgAR.
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bition activities and antioxidant activities.
The antimicrobial studies of Ag, AR and AgAR were
determined against three pathogenic microbes namely
Erwinia carotovora (Figure 9), Alternaria solani (Figure 10)
and Fusarium solani (Figure 11) at three different con-
centrations (150, 200 and 250 ppm). Silver in the form
of bare AgNPs (Ag) showed significant antibacterial
activity in comparison to AR and AgAR. However, at
the tested concentrations the activity of Ag was lesser
than the standard antibiotic streptomycin. Moreover,
the antifungal activities of Ag, AR and AgAR were not
significant in comparison to the standard fungicide
dithane-M45.
The synthesized nanoparticles AgAR, Ag and parent
compound AR were then screened for inhibition of
xanthine and urease enzymes and the results are re-
ported in Table 1. Ag and AR are found to be inactive
against these enzymes. The AgAR has shown significant
inhibition against xanthine oxidase and urease enzymes
with IC50 value of 15.5 ± 0.9 and 9.2 ± 0.9 μg/mL,Figure 4 Mechanism of synthesis of silver nanoparticles (AgAR) fromrespectively. As discussed previously our nanoconjugates
contains 9% of ligand AR, therefore the conjugation of
AR to Ag in the form of nanoconjugates AgAR not only
enhanced the enzyme inhibition activity of AR but also
reduced the amount of AR by about 11 times. Moreover,
the urease inhibition activity of AgAR was found to be
more than the standard drug thiourea with IC50 values
of 9.2 ± 0.9 and 21.8 ± 1.2 μg/mL, respectively. Its
means the conjugation of AR to Ag had a robust inhi-
bition effect in comparison to pure Ag and AR. In order
to evaluate the selectivity of AgAR towards xanthine
oxidase and urease enzymes, the activity of AgAR, Ag
and AR were also tested against the carbonic anhydrase,
α-chymotrypsin, acetylcholinesterase and butylcholines-
terase enzymes. Interestingly the AgAR, Ag and AR were
found to be inactive against these enzymes, exhibiting
their selectivity towards xanthine oxidase and urease
enzymes. In case of carbonic anhydrase AR showed
inhibitory effect against carbonic anhydrase-II, but this
effect was non-significant in comparison to standard
drug acetazolamide.
The antioxidant activity of AgAR, Ag and AR was
determined using DPPH radical scavenging assay (RSA).
Before conjugation, the antioxidant activity of AR was
significant with IC50 value of 36.55 ± 2.05 μg/mL but
after conjugation the AR lost its antioxidant activity
(Table 2). Additionally, the antioxidant effect produced
by AR in comparison to AgAR was also greater than all
the three standard drugs (ascorbic acid, butylated hydro-
xyanisole, N-acetyl cystine).
Conclusions
In conclusion, we have developed an efficient strategy for
the synthesis of silver nanoparticles capped with AR
toward selective inhibition of urease and xanthine en-
zymes. The urease and xanthine inhibition potency of
AR was amplified by conjugation to Ag. On per weight
basis, our nanoconjugates AgAR require less amount
of AR (about 11 times) for inhibition enzyme of urease
and xanthine enzymes. Moreover, our synthesizedAR.
Figure 5 Typical TEM image of AgAR.
Figure 7 Effect of salt (NaCl) on stability AgAR: After 24 h.
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and was not affected by high concentration of salt
solution and heating up to 100°C.
Methods
Materials and instruments
Silver nitrate (AgNO3), sodium borohydride (NaBH4),
sodium hydroxide (NaOH), sodium chloride (NaCl),
methanol (MeOH), dimethylformamide (DMF) and
hydrochloric acid (HCl) were purchased from Merck.
Deionized water was used for synthesis of AgNPs. A
digital pH meter model 510 (Oakton, Eutech) equipped
with a glass working electrode and a reference Ag/AgCl
electrode was used. UV–vis spectra were recorded with a
Shimadzu UV-240, Hitachi U-3200 spectrometer with a
path length of 1 cm. The FTIR spectra were recorded
using Shimadzu IR. Microscopic image of synthesized
AgNPs was taken with a Zeiss Libra transmission electron
microscope (TEM) operated at 120 keV.Figure 6 Effect of pH on stability of AgAR: After 24 h. Error bars
indicate S.D (n = 3).Synthesis of ligand and nanoparticles
Synthesis of 5-Amino-β-resorcylic acid hydrochloride
dihydrate (AR)
Synthesis of AR illustrated in Figure 1 was carried out
by our previously reported method [12]. It was used fur-
ther as a capping agent for silver nanoparticles.
Synthesis of Silver nanoparticles capped with AR (AgAR)
As AR has low solubility in water therefore a mixture of
MeOH, DMF and water (2:3:5) was used as a solvent for
its solubility. 1 mM solution of AR was prepared in re-
spective solvent and used for synthesis of AgNPs. 1 mM
solution of AgNO3 was prepared in deionized water.
Freshly prepared (40 mM in water) solution of NaBH4
was used as a reducing agent. I mL of AR and 10 mL of
Ag NO3 (1 mM) was taken and kept on stirring forFigure 8 Effect of heat on stability of AgNPs stabilize with AR:
After 24 h.
Figure 11 Antifungal activity of Ag, AR, AgAR, dithane-M45
(standard drug) and DMSO (negative control) against F. solani.
Error bars indicate S.D (n = 3).
Figure 9 Antibacterial activity of Ag, AR, AgAR, streptomycin
(standard drug) and DMSO (negative control) against E. carotovora.
Error bars indicate S.D (n = 3).
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After addition of reducing agent, the color of the re-
action mixture generally changed from light brown to
dark brown (Additional file 1: Figure S1). After 3 h
stirring, the solution was characterized by UV–vis spec-
troscopy (Figure 1). Similarly different ratios of Ag, AR
and NaBH4 were tested (Additional file 2: Table S1).
From table S1 the optimum ratio for nanoparticles for-
mation was found to be 10: 1.0: 1.0 (Ag: AR: NaBH4).
Solid silver nanoparticles capped with AR (AgAR) were
collected by freeze drying for FTIR and TEM characte-
rizations and bioactivity screening.
Bare silver nanoparticles (Ag)
10 mL of Ag NO3 (1 mM) was taken followed by drop
wise addition of NaBH4 and then kept on stirring for
30 min. Solid bare silver nanoparticles (Ag) was col-
lected after freeze drying.
Stability check of silver nanoparticles
pH effect
For pH study, 2 mL of freshly prepared AgAR was taken.
Its pH was recorded and found to be 8.49. The pH of
AgAR ranging from 10–13 was adjusted by using 1 MFigure 10 Antifungal activity of Ag, AR, AgAR, dithane-M45
(standard drug) and DMSO (negative control) against A. solani.
Each value is the mean ± S.D (n = 3).NaOH solution. Similarly, the pH of AgAR ranging from
2–7 was maintained by using 1 N HCl. The UV–vis
spectra of resulting solutions were recorded after 24 h
(Figure 6).
Salt effect
Effect of high concentration of NaCl (2–4 M) on synthe-
sized AgAR was studied. For this purpose 2 mL of
freshly prepared AgAR was taken in a beaker. Then 2
mL of 2 M NaCl solution was added to it. The resulting
solution was kept at room temperature for 24 h. Then
its UV–vis spectrum was recorded. Similarly, the effect
of 3 and 4 M NaCl was monitored by following the same
protocol (Figure 7).
Heat effect
Heat effect of synthesized nanoparticles AgAR was stu-
died by taking 10 mL of freshly prepared AgAR in a
round bottom flask (25 mL). The solution was heated up
to 100°C for 30 min. The nanoparticles was then kept at
room temperature for and its UV–vis spectrum was
recorded (Figure 8).
Bioactivity screening of silver nanoparticles
Antifungal activity
The antifungal activity was evaluated by the agar-well
diffusion method [15]. Dithane-M45 was used as a
standard drug. Three different concentration (150, 200
and 250 ppm) of standard drug and tested samples
prepared in dimethysulfoxide (DMSO). 10 μL of each
sample was uniformly dissolved in PDA (potato dextrose
agar) medium on agar plate. Using sterilized borer
mycelial plug (5 mm) of Alternaria solani and Fusarium
oxysporum f. sp. lycopersici (FOL) were fixed at the cen-
ter of the agar plate. The positive control (Dithane-M45
fungicide) and negative control (media + DMSO) were
also run in parallel for reference. The agar plate cultures
were incubated at 25°C for 7 days and growth of the
fungal strains were observed on daily basis. After
Table 1 Comparative enzyme inhibition activities of AR, Ag and AgAR
S. No Enzymes AR Ag AgAR Standard
1 Xanthine oxidase % Inhibition 8 9.5 86.8 98.6
IC50 ± S.E.M* (μg/mL) °NA NA 15.5 ± 0.9 2.0 ± 0.1
2 Carbonic anhydrase-II % Inhibition 71.2 20 0 89.0
IC50 ± S.E.M (μg/mL) 23.43 ± 1.12 NA NA 0.21 ± 0.03
3 α-Chymotrypsin % Inhibition 7 10 0 98.6
IC50 ± S.E.M (μg/mL) NA NA NA 5.7 ± 0.1
4 Acetylcholi-nesterase % Inhibition 8 5 0 98.6
IC50 ± S.E.M (μg/mL) NA NA NA 8.5 ± 0.1
5 Butylcholin-esterase % Inhibition 12 8 0 98.6
IC50 ± S.E.M (μg/mL) NA NA NA 8.5 ± 0.1
6 Urease % Inhibition 5 15 97.0 96.9
IC50 ± S.E.M(μg/mL NA NA 9.2 ± 0.9 21.8 ± 1.2
°NA = Not applicable, *S.E.M = Standard error mean.
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radial colony growth of the fungus in negative, positive
and test cultures. Percent growth Inhibition in radial
colony growth was determined in triplicate by using the
following formula.
I ¼ C − Tð Þ=C  100
I = Percentage of inhibition, C = Diameter of fungal
colony in control, T = Diameter of the fungal colony in
treatment.
Antibacterial activity
The antibacterial activity of samples was determined ac-
cording to method described by Yin et al. [16]. For this
study gram-negative bacteria Erwinia carotovora was se-
lected [17]. Streptomycin was used as a positive control.
Three different concentrations (150, 200 and 250 ppm)
of each sample and standard drug was prepared in
DMSO. In sterilized petridishes, 10 mL PDA was poured
and bacterial inoculation was carried out by streaking to
form different colonies. The disc of 5 mm was kept at
the center of agar plate and 10 μL of each sample wasTable 2 DPPH radical scavenging activities of Ag, AR and
AgAR
S. No. Code IC50 ± S.E.M (μg/mL) RSA*(%)
1 AR 36.55 ± 2.05 93
2 Ag NA 10
3 AgAR NA 5
4 AA’ 40.1 ± 1.2 96
5 BHA” 44.6 ± 0.7 95
6 NAC» 105.9 ± 1.1 95
*Radical scavenger activity, ’AA (ascorbic acid), “BHA (butylated hydroxyanisole),
»NAC (N-acetyl cystine).poured on disk. The positive control and negative
control (media + DMSO) were also run in parallel for
reference. and zone of inhibition was observed after
72 h. Percent growth of inhibition was calculated by
following formula and analysis was done in triplicate.
IE %ð Þ ¼ DC−DS=DC – 5  100
DC stands for diameter of control and 5 is the size of
disc which was 5 mm.
Xanthine oxidase inhibition assay
The XO inhibitory activity of test compounds was deter-
mined by measuring the rate of hydroxylation of the
substrate (xanthine) and subsequent formation of uric
acid, which is a colorless end product of the reaction
and showed absorption at 295 nm. Briefly, the reaction
mixture containing 10 μL of 1 mg/L pure compound or
0.2 mg/mL of nanoparticles was dissolved in DMSO,
150 μL of phosphate buffer (0.05 mol/L, pH 7.4), 0.003
units of Xanthine Oxidase dissolved in buffer (20 μL),
and 20 μL of 0.1 mmol/L xanthine as substrate for en-
zyme. After addition of xanthine oxidase, the mixture was
incubated for 10 min at room temperature and pre-read
in the UV region (λmax 295 nm). The substrate was added
to reaction mixture, and continuous reading for 15 min at
an interval of 1 min was observed (Spectra MAX-340).
The percentage inhibitory activity induced by the samples
were determined against a DMSO blank and calculated
using the following formula. Inhibition (%) = 100 - [(OD
test compound/OD control) × 100]. The IC50 of the
compounds as calculated using EZ-Fit windows-based
software (Perrella Scientific Inc. Amherst, U.S.A.). To
compare the inhibitory activities of the compounds,
allopurinol was used as standard. The reaction for each
compound was performed in triplicate [18].
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Exact 25 μL of enzyme (jack bean urease) solution and
5 μL of test compounds (0.2 mg/mL of nanoparticles)
were incubated with 55 μL of buffers containing
100 mM urea for 15 min at 30°C in each well of 96-well
plates,. Ammonia production was measured as a urease
activity by indophenol method [19]. Final volumes were
maintained as 200 μL by adding 45 μL phenol reagent
(1% w/v phenol and 0.005% w/v sodium nitroprussside)
and 70 μL of alkali reagent (0.5% w/v NaOH and 0.1%
active chloride NaOCl) to each well. Using a microplate
reader (Molecular Devices, CA, USA), the increase in
absorbance was measured at 630 nm after 50 min at
pH 6.8. The results (change in absorbance per min) were
collected using softMax Pro software (Molecular Devices,
CA, USA). Thiourea was used as the standard inhibitor
and percentage inhibitions were calculated as follow:
100-(ODtestwell/ODcontrol) × 100 [20]. The analysis was
done in triplicate.
Carbonic anhydrase-II inhibition assay
The experiment was run with the buffer containing
HEPES-Tris solution at a total concentration of 20 mM
and pH (7.2-7.9). For this 140 μL of the HEPES-Tris so-
lution was mixed with 20 μL of freshly prepared aqueous
solution of purified bovine erythrocyte CA-II (0.1-
0.2 mg/2000 μL of demonized water for 96-well), Fluka
MP Biomedicals. The test compound was dissolved in
10% DMSO, out of this 20 μL was added in a reaction
mixture, followed by the addition of 4-NPA at concen-
tration of 0.8 mM diluted in ethanol [21]. The reaction
was initiated by addition of 4-NPA after 15 min incuba-
tion of test compound. The compounds were tested in
triplicate. In this assay, the reaction was performed by
using 96-well plates. To initiate the reaction, the plate
was placed in a microplate reader and the amount of
reaction product formed was monitored at 1 min inter-
val for 30 min at 400 nm. The reaction temperature was
kept between 25–28°C.
α-Chymotrypsin assay
The inhibitory activity of α-chymotrypsin was performed
in 50 mM Tris–HCl buffer pH 7.6 with 10 mM CaCl2,
as mentioned by Cannell et al. with the slight modifica-
tion. The enzyme α-chymotrypsin (12 units/mL pre-
pared in buffer mentioned above) with the 0.5 mM test
compound prepared in DMSO, was incubated at 30°C
for 25 min. The reaction was initiated by the addition of
the chromogenic substrate, N-succinyl-L-phenylalanine-
p-nitroaniline (SPpNA; 0.4 mM final concentration pre-
pared in the buffer as above). The change in absorbance
by release of p-nitroanilide was continuously monitored
at 410 nm. The positive control without test compound
was replaced by DMSO (final concentration 7%). Theanalysis was performed in triplicate. The percentage of in-
hibition based upon initial velocity and calculated as [22]:
% Inhibition ¼ 100− ODtest=ODcontrolð Þ100
Cholinesterase Inhibition assays
Acetyl cholinesterase (AChE) and butyl cholinesterase
(BChE) inhibiting activities were measured by the spec-
trophotometric method by using acetylthiocholine iodide
and butyrylthiocholine chloride as substrates. The re-
action mixture contained 130 μL of (100 mM) sodium
phosphate buffer (pH 8.0), 20 μL of DTNB, 10 μL of
tested compound solution and 20 μL of AChE or BChE
solution, which were mixed and incubated for 15 min at
25°C. The reaction was then initiated by the addition of
20 μL acetylthiocholine or butyrylthiocholine, respec-
tively. The hydrolysis of acetylthiocholine and buty-
rylthiocholine were monitored at a wavelength of
412 nm (15 min). Absolute ethanol, which becomes 5%
in the reaction mixture, was used as solvent for test
compounds and the standard inhibitor. All the reactions
were performed in triplicate in 96-well microplate using
SpectraMax Plus 384 [23,24].
Antioxidant assay
Measurement of superoxide radical scavenging activity
was carried out by the modified method used by Ferda
[25]. The reaction mixture comprised of 40 mL of
280 mM b-nicotinamide adenine dinucleotide reduced
form (NADH), 40 mL of 80 mM nitro blue tetrazolium
(NBT), 20 mL phenazine methosulphate (PMS), 10 mL
of 0.2 mg/mL sample and 90 mL of 0.1 M phosphate
buffer (pH 7.4). Reagents were prepared in buffer solu-
tion and the sample in DMSO. The reaction was per-
formed in 96-well microtitre plate at room temperature
and absorbance was measured at 560 nm. The formation
of superoxide was monitored by measuring the forma-
tion of water soluble blue formazan dye. A lower absorb-
ance of reaction mixture indicates a higher scavenging
activity of the sample. Percent radical scavenging activity
(% RSA) by samples can be determined in comparison
with a control.
RSA %ð Þ ¼ 100– ODtestcompound=ODcontrol
 100
The reaction mixture containing 5 μL of (0.5 mg/mL)
test samples (in DMSO) and 95 mL of DPPH (300 mmol)
in ethanol, was taken in a 96-well microtitre plate and in-
cubated in ELISA (multiple reader, Spectra Max – 3400)
at 37°C for 30 min. The absorbance was measured at
515 nm. RSA (%) was determined in triplicate by com-
parison with a DMSO containing controls. Ascorbic
acid, butylated hydroxyanisole and N-acetyl cystine
were used as the positive controls [26].
Naz et al. Journal of Nanobiotechnology 2014, 12:34 Page 8 of 8
http://www.jnanobiotechnology.com/content/12/1/34Additional files
Additional file 1: Figure S1. Optical recognition of AgNO3, NaBH4, AR
and AgAR.
Additional file 2: Table S1. Optimization of reaction conditions by
changing the amount of Ag, AR and NaBH4.
Abbreviations
AR: 5-Amino-β-resorcylic acid hydrochloride dihydrate; AgAR: Silver
nanoparticles capped with AR; AgNPs: Silver nanoparticles; UV-Visible
spectra: Ultra violet-visible spectra; FTIR: Fourier transformed infrared;
TEM: Transmission electron microscope.
Competing interests
The authors state that they have no competing interests.
Authors’ contributions
SSN performed the synthesis of nanoparticles and wrote the manuscript.
MRS supervised the whole work. AK and SSA helped in interpretation of
biological data. NUI, SN and SQ helped with the analysis. All authors read
and approved the final manuscript.
Acknowledgements
We are indebted to the HEJ, Research Institute of Chemistry, ICCBS,
University of Karachi and Higher Education Commission of Pakistan for the
availability of chemicals and instruments. We thank Dr. Massimo Bertino of
Department of Physics, Virginia Commonwealth University for his assistance
with acquiring TEM images and Dr. Mohammad Aslam Baig of National
Centre of Physics, Quaid-i-Azam University Campus, Islamabad, for his
contribution in language correction of the manuscript.
Author details
1Nanoscience and Catalysis Division, National Centre for Physics,
Quaid-i-Azam University Campus, Islamabad 44000, Pakistan. 2H.E.J. Research
Institute of Chemistry, International Centre for Chemical and Biological
Sciences, University of Karachi, Karachi 75270, Pakistan. 3Institute of Chemical
Sciences, University of Peshawar, Peshawar 25120, Pakistan. 4Sarhad
University of Science and Information Technology, Peshawar 2500, Pakistan.
5Department of Plant Pathology, Khyber Pakhtunkhwa Agricultural University
Peshawar, Peshawar, Pakistan.
Received: 4 April 2014 Accepted: 29 August 2014
Published: 9 September 2014
References
1. Corma A, Garcia H: Supported gold nanoparticles as catalysts for organic
reactions. Chem Soc Rev 2008, 37(9):2096–2126.
2. Sýkora D, Kašička V, Mikšík I, Řezanka P, Záruba K, Matějka P, Král V:
Application of gold nanoparticles in separation sciences. J Sep Sci 2010,
33(3):372–387.
3. Yu DG: Formation of colloidal silver nanoparticles stabilized by Na + −poly
([gamma]-glutamic acid)-silver nitrate complex via chemical reduction
process. Colloids Surf B: Biointerfaces 2007, 59(2):171–178.
4. Kéki S, Török J, Deák G, Darķczi L, Zsuga M: Silver nanoparticles by
PAMAM-assisted photochemical reduction of Ag+. J Colloid Interface
Sci 2000, 229(2):550–553.
5. Petit C, Lixon P, Pileni MP: In situ synthesis of silver nanocluster in AOT
reverse micelles. J Phys Chem 1993, 97(49):12974–12983.
6. Sandmann G, Dietz H, Plieth W: Preparation of silver nanoparticles on ITO
surfaces by a double-pulse method. J Electroanal Chem 2000, 491(1–2):78–86.
7. Smetana AB, Klabunde KJ, Sorensen CM: Synthesis of spherical silver
nanoparticles by digestive ripening, stabilization with various agents,
and their 3-D and 2-D superlattice formation. J Colloid Interface Sci 2005,
284(2):521–526.
8. Tan Y, Wang Y, Jiang L, Zhu D: Thiosalicylic acid-functionalized silver
nanoparticles synthesized in one-phase system. J Colloid Interface Sci
2002, 249(2):336–345.
9. Abou El-Nour KMM, Eftaiha A, Al-Warthan A, Ammar RAA: Synthesis and
applications of silver nanoparticles. Arab J Chem 2010, 3(3):135–140.10. Vogt RL, Dippold L: Escherichia coli O157: H7 outbreak associated with
consumption of ground beef, June-July 2002. Public Health Rep 2005,
120(2):174–178.
11. Dar MA, Ingle A, Rai M: Enhanced antimicrobial activity of silver
nanoparticles synthesized by< i> Cryphonectria</i> sp. evaluated singly
and in combination with antibiotics. Nanomedicine 2013, 9(1):105–110.
12. Naz SS, Islam NU, Tahir MN: 5-Carboxy-2,4-dihydroxyanilinium chloride
dihydrate. Acta Cryst 2011, E67:o299.
13. Sohaila NS, Ul IN, Raza SM, Sartaj AS, Zafar I, Massimo B, Louis F, Afifa A:
Enhanced biocidal activity of Au nanoparticles synthesized in one pot
using 2, 4-dihydroxybenzene carbodithioic acid as a reducing and
stabilizing agent. J Nanobiotechnol 2013, 11(1):13.
14. Espinoza MG, Hinks ML, Mendoza AM, Pullman DP, Peterson KI: Kinetics of
Halide-Induced Decomposition and Aggregation of Silver Nanoparticles.
J Phys Chem B 2012, 116:8305–8313.
15. Ahmad B, Azam S, Bashir S, Hussain F, Chaudhary MI: Insecticidal, brine
shrimp cytotoxicity, antifungal and nitric oxide free radical scavenging
activities of the aerial parts of Myrsine africana L. Afr J Biotechnol 2011,
10(8):1448–1453.
16. Tsao S-M, Yin M-C: In-vitro antimicrobial activity of four diallyl sulphides
occurring naturally in garlic and Chinese leek oils. J Med Microbiol 2001,
50(7):646–649.
17. Toth IK, Bell KS, Holeva MC, Birch PRJ: Soft rot erwiniae: from genes to
genomes. Mol Plant Pathol 2003, 4(1):17–30.
18. Lee SK, Mbwambo ZH, Chung H, Luyengi L, Gamez EJ, Mehta RG, Kinghorn
AD, Pezzuto JM: Evaluation of the antioxidant potential of natural
products. Comb Chem High Throughput Screen 1998, 1(1):35.
19. Weatherburn M: Phenol-hypochlorite reaction for determination of
ammonia. Anal Chem 1967, 39(8):971–974.
20. Choudhary MI, Ali M, Wahab A-t, Khan A, Rasheed S, Shyaula SL, Rahman
A-u: New antiglycation and enzyme inhibitors from Parmotrema cooperi.
Sci China Chem 2011, 54(12):1926–1931.
21. Arslan O: Inhibition of bovine carbonic anhydrase by new sulfonamide
compounds. Biochem Mosc 2001, 66(9):982–983.
22. Cannell RJ, Kellam SJ, Owsianka AM, Walker JM: Results of a large scale
screen of microalgae for the production of protease inhibitors.
Planta Med 1988, 54(01):10–14.
23. Ellman GL, Courtney KD, Andres V, Featherstone RM: A new and rapid
colorimetric determination of acetylcholinesterase activity. Biochem
Pharmacol 1961, 7(88):95.
24. Gupta A, Thakur SS, Uniyal PL, Gupta R: A survey of bryophytes for
presence of cholinesterase activity. Am J Bot 2001, 88(12):2133–2135.
25. Pezzuto JM, Kosmeder JW, Park EJ, Lee SK, Cuendet M, Gills J, Bhat K,
Grubjesic S, Park H-S, Mata-Greenwood E: Characterization of natural
product as chemopreventive agents. In Cancer Chemoprevention. 2nd
edition. Edited by Kelloff GJ, Hawk ET, Sigman CC. Totowa, NJ: Humana
Press Inc; 2005:3–37. http://link.springer.com/chapter/10.1007%2F978-1-
59259-768-0_1.
26. Thadhani MV, Iqbal CM, Sajjad A, Iman O, Hina S, Veranja K: Antioxidant
activity of some lichen metabolites. Nat Prod Res 2011, 25:1827–1837.
doi:10.1186/s12951-014-0034-8
Cite this article as: Naz et al.: Synthesis and bioactivities of silver
nanoparticles capped with 5-Amino-β-resorcylic acid hydrochloride
dihydrate. Journal of Nanobiotechnology 2014 12:34.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
